Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 4
1960 16
1961 23
1962 31
1963 48
1964 45
1965 45
1966 57
1967 42
1968 57
1969 41
1970 80
1971 64
1972 58
1973 74
1974 87
1975 96
1976 104
1977 80
1978 95
1979 96
1980 93
1981 108
1982 92
1983 99
1984 104
1985 100
1986 98
1987 88
1988 75
1989 73
1990 71
1991 53
1992 54
1993 50
1994 54
1995 55
1996 42
1997 30
1998 28
1999 42
2000 29
2001 36
2002 26
2003 34
2004 34
2005 28
2006 39
2007 32
2008 30
2009 29
2010 24
2011 21
2012 33
2013 36
2014 37
2015 22
2016 24
2017 30
2018 24
2019 14
2020 23
2021 27
2022 26
2023 32
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

3,285 results

Results by year

Filters applied: . Clear all
Page 1
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Maayan N, Quraishi SN, David A, Jayaswal A, Eisenbruch M, Rathbone J, Asher R, Adams CE. Maayan N, et al. Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article. Review.
No study comparing fluphenazine decanoate with oral neuroleptics reported death or hospital admissions.No significant difference in relapse rates in the medium term between fluphenazine decanoate and fluphenazine enanthate was found (n = 49, 1 RCT, RR 2.43, C …
No study comparing fluphenazine decanoate with oral neuroleptics reported death or hospital admissions.No significant difference in r …
Depot fluphenazine for schizophrenia.
Adams CE, Eisenbruch M. Adams CE, et al. Cochrane Database Syst Rev. 2000;(2):CD000307. doi: 10.1002/14651858.CD000307. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000307. doi: 10.1002/14651858.CD000307. PMID: 10796340 Updated. Review.
The decanoate form is more frequently used but both versions were reviewed in this work. OBJECTIVES: To compare depot fluphenazine medication to oral fluphenazine for treatment of schizophrenia. ...SELECTION CRITERIA: All randomised clinical trials that compared …
The decanoate form is more frequently used but both versions were reviewed in this work. OBJECTIVES: To compare depot fluphenazine me …
Depot fluphenazine decanoate and enanthate for schizophrenia.
David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J. David A, et al. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000307. doi: 10.1002/14651858.CD000307. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Feb 05;(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. PMID: 15674872 Updated. Review.
MAIN RESULTS: This review now includes 70 randomised studies. Compared with placebo, fluphenazine decanoate did not reduce relapse over 6 months to 1 year, but one longer term study found that relapse was significantly reduced in the fluphenazine arm (n=54, RR 0.35, …
MAIN RESULTS: This review now includes 70 randomised studies. Compared with placebo, fluphenazine decanoate did not reduce relapse ov …
Fluphenazine.
Rabinowitz D. Rabinowitz D. S Afr Med J. 1984 May 12;65(19):752. S Afr Med J. 1984. PMID: 6719308 No abstract available.
Fluphenazine resistant psychosis.
Brent R, Kalman T. Brent R, et al. Can J Psychiatry. 1981 Mar;26(2):118-9. doi: 10.1177/070674378102600210. Can J Psychiatry. 1981. PMID: 7260818
She had previously responded well to treatment with trifluoperazine but because of her history of medication non-compliance, a trial of fluphenazine enanthate was instituted. Despite the close chemical similarity between trifluoperazine and fluphenazine the patient …
She had previously responded well to treatment with trifluoperazine but because of her history of medication non-compliance, a trial of f …
Fluphenazine pharmacokinetics and therapeutic response.
Dysken MW, Javaid JI, Chang SS, Schaffer C, Shahid A, Davis JM. Dysken MW, et al. Psychopharmacology (Berl). 1981;73(3):205-10. doi: 10.1007/BF00422403. Psychopharmacology (Berl). 1981. PMID: 6787637 Clinical Trial.
We conducted a double-blind study of therapeutic outcome versus mean steady-state levels in 29 newly admitted schizophrenic and schizoaffective patients who were treated with a constant dose of fluphenazine HCI over a 2-week period. both an upper and lower end of the thera …
We conducted a double-blind study of therapeutic outcome versus mean steady-state levels in 29 newly admitted schizophrenic and schizoaffect …
Fluphenazine decanoate during pregnancy.
Cleary MF. Cleary MF. Am J Psychiatry. 1977 Jul;134(7):815-6. doi: 10.1176/ajp.134.7.815. Am J Psychiatry. 1977. PMID: 869065 No abstract available.
Fluphenazine plasma levels and clinical response.
Mavroidis ML, Kanter DR, Hirschowitz J, Garver DL. Mavroidis ML, et al. J Clin Psychiatry. 1984 Sep;45(9):370-3. J Clin Psychiatry. 1984. PMID: 6381472 Clinical Trial.
Plasma levels of fluphenazine and clinical response were examined in 19 inpatient schizophrenics (DSM-III diagnoses) using a constant dose, steady-state methodology. A significant curvilinear correlation was demonstrated between clinical response and steady-state plasma le …
Plasma levels of fluphenazine and clinical response were examined in 19 inpatient schizophrenics (DSM-III diagnoses) using a constant …
Fluphenazine plasma levels and clinical response.
Marder SR, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J, Midha KK. Marder SR, et al. Psychopharmacol Bull. 1990;26(2):256-9. Psychopharmacol Bull. 1990. PMID: 2236467 Clinical Trial.
We monitored fluphenazine plasma levels in 39 schizophrenic patients who participated in a 2-year double-blind comparison of 5 mg and 25 mg of fluphenazine decanoate (FD) administered every 14 days. ...These findings suggest that the measurement of fluphenazine …
We monitored fluphenazine plasma levels in 39 schizophrenic patients who participated in a 2-year double-blind comparison of 5 mg and …
Depot fluphenazine: risk/benefit ratio.
Glazer WM. Glazer WM. J Clin Psychiatry. 1984 May;45(5 Pt 2):28-35. J Clin Psychiatry. 1984. PMID: 6370986 Review.
The risks and benefits associated with depot fluphenazine are reassessed by a review and critique of the literature, with an emphasis on controlled studies comparing depot to oral preparations. ...
The risks and benefits associated with depot fluphenazine are reassessed by a review and critique of the literature, with an emphasis …
3,285 results

Searches related to "fluphenazine"